Fertility and sterility · 2012
Use of metaphase I oocytes matured in vitro is associated with embryo multinucleation.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
De Vincentiis Sabrina, De Martino Evelyn, Buffone Mariano G, Brugo-Olmedo Santiago
Аннотация
OBJECTIVE: To evaluate the impact of oocyte maturational stage at retrieval on embryo multinucleation.
DESIGN: Retrospective study.
SETTING: Private institution for assisted reproduction.
PATIENT(S): A total of 412 patients undergoing 500 intracytoplasmic sperm injection (ICSI) cycles between August 2006 and September 2010.
INTERVENTION(S): Routine ICSI laboratory procedures.
MAIN OUTCOME MEASURE(S): Normal and abnormal fertilization; embryo development; arrest at pronuclear stage; failure to undergo first mitotic division; presence of embryo multinucleation; embryo quality; pregnancy, implantation, and miscarriage rates.
RESULT(S): A significantly lower percentage of multinucleation was found in embryos originating from metaphase II (MII) oocytes when compared with MI-II- and MI-derived oocytes. Significantly fewer multinucleated cells per embryo were observed in MII-derived oocytes. Clinical pregnancy and implantation rates were significantly higher when only embryos derived from MII oocytes were transferred.
CONCLUSION(S): Embryo multinucleation rate increases when in vitro-matured (2-5 hours incubation) MI (MI-II) oocytes are used instead of in vivo-matured oocytes in ICSI. Furthermore, all other ICSI outcome parameters are also compromised. The use of donated gametes does not modify these results.
DESIGN: Retrospective study.
SETTING: Private institution for assisted reproduction.
PATIENT(S): A total of 412 patients undergoing 500 intracytoplasmic sperm injection (ICSI) cycles between August 2006 and September 2010.
INTERVENTION(S): Routine ICSI laboratory procedures.
MAIN OUTCOME MEASURE(S): Normal and abnormal fertilization; embryo development; arrest at pronuclear stage; failure to undergo first mitotic division; presence of embryo multinucleation; embryo quality; pregnancy, implantation, and miscarriage rates.
RESULT(S): A significantly lower percentage of multinucleation was found in embryos originating from metaphase II (MII) oocytes when compared with MI-II- and MI-derived oocytes. Significantly fewer multinucleated cells per embryo were observed in MII-derived oocytes. Clinical pregnancy and implantation rates were significantly higher when only embryos derived from MII oocytes were transferred.
CONCLUSION(S): Embryo multinucleation rate increases when in vitro-matured (2-5 hours incubation) MI (MI-II) oocytes are used instead of in vivo-matured oocytes in ICSI. Furthermore, all other ICSI outcome parameters are also compromised. The use of donated gametes does not modify these results.
Предметные рубрики MeSH
Abortion, SpontaneousAdultArgentinaCell NucleusComorbidityEmbryo ImplantationEmbryo, MammalianEmbryonic DevelopmentEmbryonic InductionFemaleHumansInfertilityMetaphaseOocytesOvulation InductionPregnancyPregnancy OutcomePrevalenceRetrospective StudiesSperm Injections, IntracytoplasmicTreatment Outcome